Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00055809Phase 2Completed
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid TumorRegional Gastrointestinal Carcinoid Tumor
Principalinvestigator
NCT00454363Phase 2Completed
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more
Principalinvestigator
NCT01204476Phase 1Completed
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Agustin Garcia

University of Southern California

Related
4 trials

Shared therapeutic areas:

Metastatic Gastrointestinal Carcinoid TumorPancreatic Polypeptide TumorRecurrent Gastrointestinal Carcinoid Tumor+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid TumorRegional Gastrointestinal Carcinoid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Syma Iqbal, MD

University of Southern California

Related
5 trials

Shared therapeutic areas:

Metastatic Gastrointestinal Carcinoid TumorPancreatic Polypeptide TumorRecurrent Gastrointestinal Carcinoid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Hernan Garcia Rivello, MD

HIBA - patología clínica

Related
1 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Marcelo Serra, PhD

HIBA

Related
1 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Soledad Kleppe, MD

HIBA

Related
1 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Rodolfo Pizarro, MD

HIBA - cardiología

Related
1 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Francois Benard, MD

BC Cancer

Related
7 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Roberto F Casal

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Lung Carcinoid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Luis Mazzuoccolo, MD

HIBA - dermatología

Related
1 trials

Shared therapeutic areas:

Paraganglioma
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00055809Phase 2PrincipalInvestigator

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid TumorRegional Gastrointestinal Carcinoid Tumor
Completed
NCT00454363Phase 2PrincipalInvestigator

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more
Completed
NCT01204476Phase 1PrincipalInvestigator

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
Completed

All 3 trials loaded